You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

In Vitro Diagnostics (IVD) Products and Test Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global In Vitro Diagnostics (IVD) Products and Test market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global In Vitro Diagnostics (IVD) Products and Test market segmented into
General Chemistries
Critical Care
Urinalysis
Analyzers Blood Gases
Workstations
Others

Based on the end-use, the global In Vitro Diagnostics (IVD) Products and Test market classified into
Molecular Diagnostics
Clinical Chemistry
Diabetes and Glucose Testing
Immunochemistry
Hematology
Others

Based on geography, the global In Vitro Diagnostics (IVD) Products and Test market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Abbott Laboratories(US)
Becton Dickinson Company(US)
bioMerieux SA(France)
F. Hoffmann-La Roche Ltd.(Switzerland)
Siemens Healthcare(Germany)
Alere Inc(US)
Beckman Coulter, Inc.(US)
Bio-Rad Laboratories(US)
Hologic(US)
Ortho Clinical Diagnostics(US)
Roche Diagnostics(US)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IN VITRO DIAGNOSTICS (IVD) PRODUCTS AND TEST INDUSTRY
2.1 Summary about In Vitro Diagnostics (IVD) Products and Test Industry
2.2 In Vitro Diagnostics (IVD) Products and Test Market Trends
2.2.1 In Vitro Diagnostics (IVD) Products and Test Production & Consumption Trends
2.2.2 In Vitro Diagnostics (IVD) Products and Test Demand Structure Trends
2.3 In Vitro Diagnostics (IVD) Products and Test Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 General Chemistries
4.2.2 Critical Care
4.2.3 Urinalysis
4.2.4 Analyzers Blood Gases
4.2.5 Workstations
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Molecular Diagnostics
4.3.2 Clinical Chemistry
4.3.3 Diabetes and Glucose Testing
4.3.4 Immunochemistry
4.3.5 Hematology
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 General Chemistries
5.2.2 Critical Care
5.2.3 Urinalysis
5.2.4 Analyzers Blood Gases
5.2.5 Workstations
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Molecular Diagnostics
5.3.2 Clinical Chemistry
5.3.3 Diabetes and Glucose Testing
5.3.4 Immunochemistry
5.3.5 Hematology
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 General Chemistries
6.2.2 Critical Care
6.2.3 Urinalysis
6.2.4 Analyzers Blood Gases
6.2.5 Workstations
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Molecular Diagnostics
6.3.2 Clinical Chemistry
6.3.3 Diabetes and Glucose Testing
6.3.4 Immunochemistry
6.3.5 Hematology
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 General Chemistries
7.2.2 Critical Care
7.2.3 Urinalysis
7.2.4 Analyzers Blood Gases
7.2.5 Workstations
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Molecular Diagnostics
7.3.2 Clinical Chemistry
7.3.3 Diabetes and Glucose Testing
7.3.4 Immunochemistry
7.3.5 Hematology
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 General Chemistries
8.2.2 Critical Care
8.2.3 Urinalysis
8.2.4 Analyzers Blood Gases
8.2.5 Workstations
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Molecular Diagnostics
8.3.2 Clinical Chemistry
8.3.3 Diabetes and Glucose Testing
8.3.4 Immunochemistry
8.3.5 Hematology
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 General Chemistries
9.2.2 Critical Care
9.2.3 Urinalysis
9.2.4 Analyzers Blood Gases
9.2.5 Workstations
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Molecular Diagnostics
9.3.2 Clinical Chemistry
9.3.3 Diabetes and Glucose Testing
9.3.4 Immunochemistry
9.3.5 Hematology
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories(US)
10.1.2 Becton Dickinson Company(US)
10.1.3 bioMerieux SA(France)
10.1.4 F. Hoffmann-La Roche Ltd.(Switzerland)
10.1.5 Siemens Healthcare(Germany)
10.1.6 Alere Inc(US)
10.1.7 Beckman Coulter, Inc.(US)
10.1.8 Bio-Rad Laboratories(US)
10.1.9 Hologic(US)
10.1.10 Ortho Clinical Diagnostics(US)
10.1.11 Roche Diagnostics(US)
10.2 In Vitro Diagnostics (IVD) Products and Test Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories(US)
10.2.2 Becton Dickinson Company(US)
10.2.3 bioMerieux SA(France)
10.2.4 F. Hoffmann-La Roche Ltd.(Switzerland)
10.2.5 Siemens Healthcare(Germany)
10.2.6 Alere Inc(US)
10.2.7 Beckman Coulter, Inc.(US)
10.2.8 Bio-Rad Laboratories(US)
10.2.9 Hologic(US)
10.2.10 Ortho Clinical Diagnostics(US)
10.2.11 Roche Diagnostics(US)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2021
  • NO OF PAGES: 115